분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-03-23 13:01:09 , Hit : 773
 Using Gene Editing to Delete HIV from Human T Cells

GEN News Highlights

Mar 22, 2016

Researchers at Temple University used a CRISPR gene editing technique to remove HIV from the DNA of human cells grown in culture. Their study ("Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing") is published In Scientific Reports.

According to senior investigator on the new study, Kamel Khalili, Ph.D., Laura H. Carnell Professor and Chair of the Department of Neuroscience, Director of the Center for Neurovirology, and Director of the Comprehensive NeuroAIDS Center at the Lewis Katz School of Medicine at Temple University (LKSOM), "Antiretroviral drugs are very good at controlling HIV infection. But patients on antiretroviral therapy who stop taking the drugs suffer a rapid rebound in HIV replication." The presence of numerous copies of HIV weakens the immune system and eventually causes acquired immune deficiency syndrome, or AIDS.

Curing HIV/AIDS, which has claimed the lives of more than 25 million people since it was first discovered in the early 1980s, is the ultimate goal in HIV research. But eliminating the virus after it has become integrated into CD4+ T cells, the cells primarily infected with HIV, has proven difficult. Recent attempts have focused on intentionally reactivating HIV, aiming to stimulate a robust immune response capable of eradicating the virus from infected cells. However, to date, none of these "shock-and-kill" approaches has been successful.

Dr. Khalili and colleagues decided to try a different approach, specifically targeting HIV-1 proviral DNA using uniquely tailored gene editing technology. Their system includes a guide RNA that specifically locates HIV-1 DNA in the T cell genome, and a nuclease enzyme, which cuts the strands of T-cell DNA. Once the nuclease has edited out the HIV-1 DNA sequence, the loose ends of the genome are reunited by the cell's own DNA repair machinery.

In previous work, Dr. Khalili's team had demonstrated the ability of their technology to snip out HIV-1 DNA from human cell lines. In their latest study, however, they concentrated on latently and productively infected CD4+ T cells to show not only that the technology eliminates the virus from cells but also that its persistent presence in HIV-1–eradicated cells actually protects them against reinfection. More importantly, they carried their work over to ex vivo experiments in which T cells from patients infected with HIV were grown in cell culture, showing that treatment with the gene editing system can suppress viral replication and dramatically reduce viral load in patient cells.

In another major component of the study, Dr. Khalili's team addressed questions about off-target effects and toxicity. Using an approach known as ultra-deep whole-genome sequencing, which is considered the gold standard for genomic assessment, the researchers analyzed the genomes of HIV-1–eradicated cells for mutations in genes outside the region targeted by the guide RNA. Their analyses ruled out off-target effects on genes, including potential collateral effects on cellular gene expression. Studies of cell viability and proliferation showed that HIV-1–eradicated cells were growing and functioning normally.

"The findings are important on multiple levels," Dr. Khalili said. "They demonstrate the effectiveness of our gene editing system in eliminating HIV from the DNA of CD4 T cells and, by introducing mutations into the viral genome, permanently inactivating its replication. Further, they show that the system can protect cells from reinfection and that the technology is safe for the cells, with no toxic effects."

"These experiments had not been performed previously to this extent," he added. "But the questions they address are critical, and the results allow us to move ahead with this technology."








1127   Mysterious Eukaryote Missing Mitochondria  이성욱 2016/05/17 851
1126   Genetically Engineered Pigs May Fly as Cancer Models  이성욱 2016/05/17 922
1125   Blame Daddy for Some Epigenetically Induced Birth Defects in Children  이성욱 2016/05/17 930
1124   RNA 세상: 태초에 RNA의 퓨린은 어떻게 생성되었나?  이성욱 2016/05/13 1398
1123   Three studies show that the virus can cause birth defects in mouse embryos.  이성욱 2016/05/13 1580
1122   ‘로렌조 오일’ 유전자 치료로 효과  이성욱 2016/05/09 848
1121   First Data from Anti-Aging Gene Therapy  이성욱 2016/04/28 866
1120   정밀의학의 끝: 개인화된 종양백신을 개발하는 과학자들  이성욱 2016/04/26 1058
1119   CRISPR Aids Identification of Sporadic Parkinson’s Mutation in GWAS  이성욱 2016/04/22 841
1118   바이오통신원 [바이오토픽] 이제는 염기편집 시대, Cas9를 변형하여 DNA 한 글자만 바꾼다.  이성욱 2016/04/21 1168
1117   Hitting HIV with CRISPR/Cas9 Can Arouse Resistance  이성욱 2016/04/10 865
1116   GSK Gets Positive CHMP Opinion For Strimvelis To Treat Rare Disease ADA-SCID  이성욱 2016/04/02 1033
1115   CRISPR Can Tag RNA  이성욱 2016/03/26 798
1114   미니멀세포(minimal cell)를 만든 크레이그 벤터  이성욱 2016/03/26 953
1113   Minimal Genome Created  이성욱 2016/03/26 830
  Using Gene Editing to Delete HIV from Human T Cells  이성욱 2016/03/23 773
1111   RNA May Surpass DNA in Precision Medicine  이성욱 2016/03/23 819
1110   Zika Update  이성욱 2016/03/15 754
1109   CRISPR/Cas9을 이용하여 PRRS 바이러스에 감염되지 않는 돼지를 개발하다  이성욱 2016/03/14 1203
1108   유전자 가위, 매머드 복원-안전한 백신의 시대 리본 자르다  이성욱 2016/03/14 987

[1][2][3][4][5][6][7] 8 [9][10]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN